Interra Health Named Quarterfinalist for AI Award
The health tech firm aims to reduce medication non-adherence by providing price transparency at the point of care.
Updated on Sept. 28, 2026 in Healthcare
Live Poll
Do you believe digital health tools effectively help you manage your medication adherence?
Interra Health has been named a quarterfinalist in the 2026 Digital Health & AI Awards under the Therapeutics, Pharmacy & Medication Innovation category. The firm utilizes its Patient Connect platform to help address the widespread issue of prescription non-adherence.
Why it matters
Non-adherence to prescriptions for chronic conditions currently contributes to $300 billion in annual avoidable healthcare costs. Interra Health seeks to mitigate this burden by integrating coverage, prescribing, and pricing insights directly into clinical workflows.
Non-adherence drives $300 billion in annual avoidable healthcare costs, a figure the Digital Health Hub Foundation ecosystem of 30,000+ members aims to address. Interra Health intends to scale its Patient Connect platform to reach millions more patients throughout the current year.
The players
Interra Health
A health technology company that provides platforms for medication access, pricing transparency, and prescription management.
Digital Health Hub Foundation
A professional ecosystem of over 30,000 members that organizes industry awards to recognize advancements in digital health and artificial intelligence.
The details
The Patient Connect platform functions by consolidating coverage data, prescription access, and pricing transparency at the point of care. It leverages technical capabilities from partners including DoseSpot, Arrive Health, and pVerify to streamline the prescribing process. The platform is currently being evaluated by a panel of leaders across the investment, technology, and clinical care sectors.
Timeline
September 28, 2026: Interra Health was named a quarterfinalist.
October 12, 2026: Finalists will be announced.
November 16, 2026: The awards program will conclude at a Grand Finale in Las Vegas.
Market Landscape
This selection follows the pattern of the 2026 Digital Health & AI Awards in vetting healthcare innovators against specific metrics of clinical and financial impact. The recognition highlights an industry-wide trend toward integrating real-time price transparency tools into standard physician workflows.
Operators in the pharmacy and clinical space should monitor how point-of-care transparency tools affect prescription abandonment rates. Tracking these metrics can help determine whether to adopt similar integrated platforms to improve patient adherence and administrative efficiency.
The takeaway
The platform's recognition underscores the growing focus on price transparency as a mechanism to lower avoidable healthcare expenditures. Administrators should monitor the platform's scaling progress this year to evaluate its potential impact on local patient outcomes.
What happens next
The program will announce its list of finalists on October 12, 2026, followed by the Grand Finale event on November 16, 2026.
Further reading
For more on industry innovations, visit the Healthcare section.
More information
View Interra Health company information for additional details on their platform capabilities.
Live Poll
Do you believe digital health tools effectively help you manage your medication adherence?
